Type II kinase inhibitors that target Parkinson's disease-associated LRRK2 Raig ND, Surridge KJ, Sanz-Murillo M, … Knapp S · Sci Adv 11(23):eadt2050 (2025) How AssayQuant was used: This publication cites AssayQuant's PhosphoSens® technology. LRRK2 assay → Ser/Thr kinase Inhibitor discovery & SARMechanism & structural biology PhosphoSens Read the paper View on PubMed